United States News Todas as matérias

Marex Group (NASDAQ:MRX) announced Monday that it has acquired Levmet, a Monaco-based liquidity provider, in a move to strengthen its physical market-making operations and secure a firmer foothold in European power and gas trading.

Jade Biosciences (NASDAQ:JBIO) delivered a significant milestone for its autoimmune pipeline, reporting positive interim results from its Phase 1 clinical trial evaluating JADE101.

Monopar Therapeutics (NASDAQ:MNPR) announced encouraging mid-stage clinical results for its investigational Wilson disease therapy, demonstrating widespread stabilization in liver pathology alongside substantial neurological and quality-of-life improvements.

C1 Fund (NYSE:CFND) released its financial results for the first quarter ended March 31, 2026, revealing a net asset value (NAV) of $48,906,337, or $7.34 per share, against a backdrop of accelerating initial public offering activity within its private digital asset portfolio.

Citius Oncology (NASDAQ:CTOR) showcased positive early-stage clinical trial results, demonstrating the potential of its targeted immune therapy LYMPHIR to enhance the efficacy of checkpoint inhibitors in treating recurrent or refractory gynecologic cancers.

Invivyd (NASDAQ:IVVD) completed enrollment for the pivotal Phase 3 clinical trial of its leading monoclonal antibody candidate, positioning the biotechnology firm to deliver late-stage results later this quarter.

Science Applications International Corp. (NASDAQ:SAIC) raised its full-year profitability and earnings forecasts after a steady opening quarter marked by expanding operating margins and an accumulation of new federal contract awards.

Bristol Myers Squibb (NYSE:BMY) secured a major regulatory milestone on Monday as the European Commission approved its blockbuster immunotherapy Opdivo in combination with chemotherapy for patients fighting advanced blood cancer.

Motorola Solutions (NYSE:MSI) has entered into a definitive agreement to acquire counter-drone technology leader D-Fend Solutions for a total purchase price of $1.5 billion, marking an aggressive move to secure a dominant position in the rapidly expanding airspace security market.

Community Financial System (NYSE:CBU) has finalized its acquisition of ClearPoint Federal Bank & Trust in an all-cash transaction valued at $39 million, absorbing a prominent administrator within the niche death care asset management market.

Parsons (NYSE:PSN) announced Monday that it has been awarded a $99 million single-award task order from the U.S. Air Force Research Laboratory (AFRL) to expand its development of advanced tactical command and control systems alongside space-based intelligence architectures.

FedEx (NYSE:FDX) completed the separation of its less-than-truckload operational unit on Monday, launching FedEx Freight Holding Company (NYSE:FDXF) as an independent, publicly traded entity on the New York Stock Exchange.

Kenon Holdings (NYSE:KEN) delivered a substantial acceleration in top-line growth for the first quarter of 2026, heavily driven by strategic operational scaling and asset consolidation within its primary power generation subsidiary, OPC Energy.

Robo.ai (NASDAQ:AIIO) announced Monday that it has officially finalized the 100% equity acquisition of Neurovia AI.

EUDA Health Holdings (NASDAQ:EUDA) announced the expansion of its proprietary Helixé product portfolio with the commercial launch of the Regenixé iPSC-derived Skin Stem Cell Secretome Mask.

Agios Pharmaceuticals (NASDAQ:AGIO) has acquired an exclusive global license for Oscotec's cevidoplenib, an experimental oral treatment for a rare blood disorder, betting the asset can capture up to $1 billion in peak U.S. sales despite recently missing the main goal of a mid-stage trial.

Moderna (NASDAQ:MRNA) has expanded its strategic collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of an experimental vaccine targeting the Bundibugyo ebolavirus strain, an aggressive cause of Ebola virus disease for which there are currently no approved or licensed immunizations.

Li Auto (NASDAQ:LI) announced Monday that it delivered 33,350 vehicles in May 2026, securing steady volume as the premium automaker kickstarts a fresh product refresh cycle across its smart electric vehicle lineup.

Oil prices climbed sharply in early Asian trading on Monday as a significant escalation of military activity across the Middle East intensified fears of a prolonged disruption to global energy supplies, overshadowing weak economic indicators from China.

NIO (NYSE:NIO) reported total deliveries of 37,705 vehicles for May 2026, representing a 62.3% increase compared to the same period last year.

XPENG (NYSE:XPEV) announced total vehicle deliveries of 32,158 units for May 2026, continuing a steady upward path in the highly competitive smart electric vehicle market.

Camurus (NASDAQ:CAMX) announced Monday that Eli Lilly (NYSE:LLY) has formally exercised its option to integrate amylin receptor agonists into the companies' existing cardiometabolic collaboration and license agreement.

Lucid Group (NASDAQ:LCID) announced that Silvio Napoli has officially assumed the role of Chief Executive Officer (CEO), effective immediately.

Uber Technologies (NYSE:UBER) and Israel-based autonomous vehicle technology developer Autobrains announced on Monday a joint initiative to launch a commercial robotaxi program in Munich, marking an expansive push to scale autonomous ride-hailing infrastructure across Europe.